Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Apotex Corp.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Apotex Corp. with status Current. The shortage was first posted on Nov 1, 2023.

Shortage details

Status
Current
Company
Apotex Corp.
Package NDC
60505-4742-1
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)
Initial Posting
Nov 1, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.